Stanley Laman Group Ltd. Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Stanley Laman Group Ltd. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,570 shares of the healthcare conglomerate’s stock after purchasing an additional 1,145 shares during the period. Stanley Laman Group Ltd.’s holdings in UnitedHealth Group were worth $2,304,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Accel Wealth Management purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $26,000. Front Row Advisors LLC raised its stake in shares of UnitedHealth Group by 288.0% in the 3rd quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 72 shares during the period. Knuff & Co LLC raised its stake in shares of UnitedHealth Group by 666.7% in the 3rd quarter. Knuff & Co LLC now owns 115 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 100 shares during the period. Ossiam raised its stake in shares of UnitedHealth Group by 42.5% in the 3rd quarter. Ossiam now owns 124 shares of the healthcare conglomerate’s stock valued at $39,000 after acquiring an additional 37 shares during the period. Finally, Costello Asset Management INC raised its stake in shares of UnitedHealth Group by 500.0% in the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 100 shares during the period. 86.03% of the stock is currently owned by institutional investors and hedge funds.

In related news, CAO Thomas E. Roos sold 619 shares of the company’s stock in a transaction on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the sale, the chief accounting officer now owns 31,908 shares in the company, valued at approximately $10,335,001.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $342.00, for a total transaction of $855,000.00. Following the completion of the sale, the director now owns 159,487 shares of the company’s stock, valued at approximately $54,544,554. The disclosure for this sale can be found here. Insiders have sold a total of 37,293 shares of company stock valued at $12,886,401 in the last 90 days. Insiders own 0.80% of the company’s stock.

UNH has been the topic of a number of research analyst reports. Mizuho boosted their price target on shares of UnitedHealth Group from $361.00 to $380.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Barclays restated a “buy” rating and issued a $405.00 price objective on shares of UnitedHealth Group in a report on Sunday, January 17th. SVB Leerink lifted their price objective on shares of UnitedHealth Group from $378.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, December 14th. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a report on Wednesday, December 2nd. They noted that the move was a valuation call. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a report on Thursday, January 21st. Five equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $387.82.

Shares of NYSE:UNH traded up $1.13 during trading on Tuesday, hitting $328.77. 81,795 shares of the company were exchanged, compared to its average volume of 3,453,442. The stock has a market capitalization of $311.94 billion, a P/E ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 12-month low of $187.72 and a 12-month high of $367.95. The firm’s 50 day moving average price is $341.25 and its 200-day moving average price is $330.10.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.39 by $0.13. The business had revenue of $65.47 billion during the quarter, compared to the consensus estimate of $64.98 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The company’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.90 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

See Also: Analyst Ratings Trading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.